Methodology

All entries for: Biogenera SpA

October 16, 2025

Biogenera SpA

Orphan Drug Designation

FDA orphan drug designation: treatment of soft tissue sarcoma

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top